Home / Sweden / Immunovia AB (publ)
Immunovia AB (publ)
Short position disclosed on July 3, 2026.
0.69% of the capital sold short
1 disclosing funds
54 disclosures on record
SE0006091997 ISIN code
Evolution of the disclosed total
0%1%2%3%4%
Oct 2025Jan 2026Apr 2026Jul 2026
February 18, 2021 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Two Sigma Investments, LP | 0.69% | new | July 3, 2026 |
On the other side: the funds that hold Immunovia AB (publ) Titelia
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| March 25, 2021 | Voleon Capital Management LP | 0.60% | still open |
| March 12, 2021 | Voleon Capital Management LP | 0.57% | still open |
| February 22, 2021 | Voleon Capital Management LP | 0.60% | still open |
| February 18, 2021 | Voleon Capital Management LP | 0.54% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.36% of the capital sold short
- Elekta AB (publ) 10.19% of the capital sold short
- JM AB 7.01% of the capital sold short
- Hemnet Group AB (publ) 6.08% of the capital sold short
- Bonesupport Holding AB 5.58% of the capital sold short
- Truecaller AB 5.43% of the capital sold short
- Embracer Group AB 5.25% of the capital sold short
- Xvivo Perfusion Aktiebolag 4.91% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- Dynavox Group AB 4.30% of the capital sold short
- RaySearch Laboratories AB (publ) 4.15% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Immunovia AB (publ), source Finansinspektionen, data as at July 3, 2026, https://www.quivad.com/action/immunovia-ab-publ?page=2